Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eligard 6-month on Biomarkers in Metastatic Prostate Cancer
NCT01933022Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Aug 2014
- Primary completion
- Aug 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of leuprolide in Metastatic Prostate Cancer (mPC), sponsored by Astellas Pharma. Started Aug 2014; status: terminated.
02
Drugs
leuprolide
03
Conditions
Metastatic Prostate Cancer (mPC)
Beyond the preview
Go deeper on NCT01933022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01933022.